Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Kintor Pharmaceutical Limited

Market Cap 958M 1.11B 142M 123M 114M 107M 201M 13.36B 202M 1.36B 526M 6.58B 531M 520M 22.83B P/E 2024
-2.53x
P/E 2025 -3.96x
Enterprise Value 1.01B 1.17B 150M 130M 121M 113M 212M 14.11B 213M 1.43B 555M 6.95B 561M 549M 24.12B EV / Sales 2024
75,794,130x
EV / Sales 2025 28,245,180x
Free-Float
83.1%
Yield 2024 *
-
Yield 2025 -
1 day-1.75%
1 week-4.66%
Current month-2.17%
1 month-19.35%
3 months-46.30%
6 months+17.80%
Current year+14.80%
1 week 2.23
Extreme 2.23
2.45
1 month 2.17
Extreme 2.17
2.84
Current year 1.96
Extreme 1.96
4.7
1 year 1.44
Extreme 1.44
4.7
3 years 0.79
Extreme 0.79
4.7
5 years 0.79
Extreme 0.79
89
10 years 0.79
Extreme 0.79
89
Manager TitleAgeSince
Chief Executive Officer 64 2009-03-23
Director of Finance/CFO 49 2023-04-13
Chief Tech/Sci/R&D Officer 49 2020-08-31
Director TitleAgeSince
Director/Board Member 62 2019-08-11
Director/Board Member 61 2019-08-11
Chairman 64 2009-03-23
Date Insider Type Main position Quantity % Market Cap.
06-08Other

Chief Executive Officer

75,000 0.0150%
05-20Other

Chief Executive Officer

38,000 0.0076%
05-17Other

Chief Executive Officer

170,000 0.0341%
Change 5-day change 1-year change 3-year change Capi.($)
-1.75%-4.66%+43.31%-46.04% 142M
+1.44%-1.25%+63.52%+114.88% 54.44B
+4.60%+5.82%+56.35%+43.04% 45.8B
-1.44%+1.51%-12.94%-19.24% 22.98B
-2.69%-0.95%-3.68%+379.00% 20.76B
+3.22%+2.94%+24.02%-35.05% 16.25B
+0.58%+1.08%+16.73%-38.06% 15.34B
-1.01%-2.97%+27.42%+171.92% 13.05B
+3.07%+5.43%+21.37% - 12.37B
+4.95%+13.49%+121.11%+249.05% 12.47B
Average +1.10%+1.50%+35.72%+91.06% 21.36B
Weighted average by Cap. +1.63%+1.38%+39.56%+98.60%

Financials

2024 2025
Net sales 5 5.79 0.74 0.64 0.6 0.56 1.05 69.7 1.05 7.08 2.74 34.31 2.77 2.71 119.13 32.68 37.84 4.83 4.21 3.9 3.65 6.85 455.6 6.89 46.25 17.93 224.25 18.12 17.74 778.66
Net income -155M -180M -22.94M -20M -18.53M -17.34M -32.53M -2.16B -32.72M -220M -85.18M -1.07B -86.12M -84.27M -3.7B -200M -232M -29.56M -25.78M -23.87M -22.35M -41.91M -2.79B -42.17M -283M -110M -1.37B -111M -109M -4.77B
Net Debt -15.68M -18.15M -2.32M -2.02M -1.87M -1.75M -3.28M -219M -3.3M -22.19M -8.6M -108M -8.7M -8.51M -374M 53.86M 62.36M 7.96M 6.94M 6.43M 6.02M 11.28M 751M 11.35M 76.23M 29.54M 370M 29.87M 29.23M 1.28B
Logo Kintor Pharmaceutical Limited
Kintor Pharmaceutical Ltd is an investment holding company primarily engaged in the research and development of innovative medicine products. The Company's products are dedicated to addressing disease areas that have not met clinical needs, and its pipeline mainly covers indications of dermatology (such as androgenetic alopecia, acne vulgaris) and indications of tumors. The Company has two core drugs in the dermatology field, KX-826 and GT20029. The Company's other disease areas include metastatic castration-resistant prostate cancer (mCRPC), liver cancer, idiopathic pulmonary fibrosis, malignant blood diseases and various solid tumors.
Employees
123
Date Price Change Volume
26-06-18 2.250 $ -1.75% 451,000
26-06-17 2.290 $ -2.55% 639,000
26-06-16 2.350 $ 0.00% 711,500
26-06-15 2.350 $ -2.08% 523,500
26-06-12 2.400 $ +1.69% 415,500

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 9939 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!